Diversity and Function of Glial Cell Types in Multiple Sclerosis
Trends in Immunology, ISSN: 1471-4906, Vol: 42, Issue: 3, Page: 228-247
2021
- 54Citations
- 15Usage
- 115Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations54
- Citation Indexes54
- 54
- CrossRef25
- Usage15
- Abstract Views15
- Captures115
- Readers115
- 115
Review Description
Glial subtype diversity is an emerging topic in neurobiology and immune-mediated neurological diseases such as multiple sclerosis (MS). We discuss recent conceptual and technological advances that allow a better understanding of the transcriptomic and functional heterogeneity of oligodendrocytes (OLs), astrocytes, and microglial cells under inflammatory–demyelinating conditions. Recent single cell transcriptomic studies suggest the occurrence of novel homeostatic and reactive glial subtypes and provide insight into the molecular events during disease progression. Multiplexed RNA in situ hybridization has enabled ‘mapping back’ dysregulated gene expression to glial subtypes within the MS lesion microenvironment. These findings suggest novel homeostatic and reactive glial-cell-type functions both in immune-related processes and neuroprotection relevant to understanding the pathology of MS.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1471490621000053; http://dx.doi.org/10.1016/j.it.2021.01.005; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85100964250&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/33593693; https://linkinghub.elsevier.com/retrieve/pii/S1471490621000053; https://escholarship.umassmed.edu/faculty_pubs/1988; https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3007&context=faculty_pubs; https://dx.doi.org/10.1016/j.it.2021.01.005
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know